UPDATE 1-Lawsuit vs Pfizer over Celebrex, Bextra safety is revived

April 12 (Reuters) - A federal appeals court on Tuesday

revived a long-running class-action lawsuit accusing Pfizer Inc

of misleading shareholders about the safety of its

Celebrex and Bextra pain-relieving drugs.

Read more